Savara Inc (SVRA)

Jan 01, 2025

Savara Inc (NASDAQ:SVRA) Receives $9.86 Consensus Target Price from Analysts - MarketBeat

Jan 01, 2025

Jan 01, 2025

Geode Capital Management LLC Raises Stock Holdings in Savara Inc (NASDAQ:SVRA) - Defense World

Jan 01, 2025

Jan 01, 2025

Geode Capital Management LLC Buys 264,825 Shares of Savara Inc (NASDAQ:SVRA) - MarketBeat

Jan 01, 2025

Dec 31, 2024

Barclays PLC Increases Stock Position in Savara Inc (NASDAQ:SVRA) - Defense World

Dec 31, 2024

Dec 29, 2024

Who Really Pulls the Strings at Savara? Discover the Power Players! - Jomfruland.net

Dec 29, 2024

Dec 29, 2024

Savara Inc. (NASDAQ:SVRA) is largely controlled by institutional shareholders who own 53% of the company - Yahoo Finance

Dec 29, 2024

Dec 29, 2024

Savara Inc. Grants Inducement Awards to New Employees - MSN

Dec 29, 2024

Dec 28, 2024

Savara Begins FDA Submission for Rare Lung Disease Treatment - MSN

Dec 28, 2024

Dec 27, 2024

Savara Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference - MSN

Dec 27, 2024

Dec 25, 2024

State Street Corp Acquires 560,242 Shares of Savara Inc (NASDAQ:SVRA) - MarketBeat

Dec 25, 2024

Dec 25, 2024

State Street Corp Purchases 560,242 Shares of Savara Inc (NASDAQ:SVRA) - Defense World

Dec 25, 2024

Dec 23, 2024

Savara Strengthens Team with Strategic Equity Incentives: 200,000 Shares Awarded to New Hires - StockTitan

Dec 23, 2024

Dec 23, 2024

Savara Announces New Employment Inducement Grant - Business Wire

Dec 23, 2024

Dec 21, 2024

Savara (NASDAQ:SVRA) Earns “Market Outperform” Rating from JMP Securities - Defense World

Dec 21, 2024

Dec 21, 2024

Wells Fargo Initiates Coverage of Savara (SVRA) with Overweight Recommendation - MSN

Dec 21, 2024

Dec 21, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 6,141 Shares of Savara Inc (NASDAQ:SVRA) - Defense World

Dec 21, 2024

Dec 20, 2024

Savara: Rolling BLA Submission Of MOLBREEVI Generates Catalysts To Track (NASDAQ:SVRA) - Seeking Alpha

Dec 20, 2024

Dec 20, 2024

Savara (NASDAQ:SVRA) Earns Overweight Rating from Analysts at Wells Fargo & Company - MarketBeat

Dec 20, 2024

Dec 19, 2024

Savara's SWOT analysis: rare disease biotech stock poised for growth By Investing.com - Investing.com Australia

Dec 19, 2024

Dec 19, 2024

Savara's SWOT analysis: rare disease biotech stock poised for growth - Investing.com

Dec 19, 2024

Dec 19, 2024

Savara (NASDAQ:SVRA) Trading 5.6% HigherTime to Buy? - MarketBeat

Dec 19, 2024

Dec 19, 2024

BNP Paribas Financial Markets Purchases 18,534 Shares of Savara Inc (NASDAQ:SVRA) - Defense World

Dec 19, 2024

Dec 19, 2024

JMP Securities Reaffirms "Market Outperform" Rating for Savara (NASDAQ:SVRA) - MarketBeat

Dec 19, 2024

Dec 18, 2024

Savara Initiates Rolling Submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for MOLBREEVI* for the Potential Treatment of Autoimmune Pulmonary Alveolar Proteinosis (aPAP) - Business Wire

Dec 18, 2024

Dec 18, 2024

Savara's MOLBREEVI Advances Toward First-Ever aPAP Treatment with FDA Rolling BLA Submission - StockTitan

Dec 18, 2024

Dec 17, 2024

Savara Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference - BioSpace

Dec 17, 2024

Dec 17, 2024

Savara's CFO David Lowrance sells $83,277 in stock By Investing.com - Investing.com South Africa

Dec 17, 2024

Dec 17, 2024

The Manufacturers Life Insurance Company Acquires 3,706 Shares of Savara Inc (NASDAQ:SVRA) - Defense World

Dec 17, 2024

Dec 17, 2024

Savara director Hawkins sells $26,568 in stock By Investing.com - Investing.com Australia

Dec 17, 2024

Dec 17, 2024

Savara director Hawkins sells $26,568 in stock - Investing.com India

Dec 17, 2024

Dec 17, 2024

Savara CEO Matthew Pauls sells $180,828 in stock - Investing.com India

Dec 17, 2024

Dec 16, 2024

Savara's SWOT analysis: molgramostim's promise buoys stock amid challenges - Investing.com

Dec 16, 2024

Dec 16, 2024

Savara Inc (NASDAQ:SVRA) CEO Matthew Pauls Sells 54,702 Shares - MarketBeat

Dec 16, 2024

Dec 16, 2024

Savara's CFO David Lowrance sells $83,277 in stock - Investing.com

Dec 16, 2024

Dec 16, 2024

Savara CEO Matthew Pauls sells $180,828 in stock By Investing.com - Investing.com Canada

Dec 16, 2024

Dec 15, 2024

Charles Schwab Investment Management Inc. Boosts Stake in Savara Inc (NASDAQ:SVRA) - MarketBeat

Dec 15, 2024

Dec 15, 2024

Charles Schwab Investment Management Inc. Buys 642,259 Shares of Savara Inc (NASDAQ:SVRA) - Defense World

Dec 15, 2024

Dec 14, 2024

Janus Henderson Group PLC Decreases Stock Position in Savara Inc (NASDAQ:SVRA) - MarketBeat

Dec 14, 2024

Dec 13, 2024

Wellington Management Group LLP Acquires 1,608,522 Shares of Savara Inc (NASDAQ:SVRA) - MarketBeat

Dec 13, 2024

Dec 13, 2024

XChain, VARA’s Exclusive Transaction Monitoring Partner, Readies Rollout for Regional and Global VASPs - GlobeNewswire Inc.

Dec 13, 2024

Dec 10, 2024

Savara Inc (NASDAQ:SVRA) Receives $10.17 Average PT from Brokerages - Defense World

Dec 10, 2024

Dec 07, 2024

Savara Inc (NASDAQ:SVRA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Dec 07, 2024

Dec 07, 2024

Intech Investment Management LLC Invests $174,000 in Savara Inc (NASDAQ:SVRA) - Defense World

Dec 07, 2024

Dec 05, 2024

Savara's SWOT analysis: molgramostim's promise lifts rare disease stock - Investing.com

Dec 05, 2024

Nov 30, 2024

Savara (NASDAQ:SVRA) Shares Down 3.2%Here's What Happened - MarketBeat

Nov 30, 2024

Nov 29, 2024

Savara Inc. Announces Stock Awards for New Employees - MSN

Nov 29, 2024

Nov 29, 2024

Savara Inc (NASDAQ:SVRA) Stock Holdings Lifted by Vestal Point Capital LP - MarketBeat

Nov 29, 2024